Changes of placental three-dimensional power Doppler ultrasonography in third trimester among hypertensive disorders complicating pregnancy.


Journal

Biomolecules & biomedicine
ISSN: 2831-090X
Titre abrégé: Biomol Biomed
Pays: Bosnia and Herzegovina
ID NLM: 9918522188506676

Informations de publication

Date de publication:
04 Sep 2023
Historique:
received: 25 03 2023
accepted: 28 04 2023
medline: 7 9 2023
pubmed: 17 5 2023
entrez: 17 5 2023
Statut: epublish

Résumé

Hypertensive disorders complicating pregnancy (HDCP) represent a systemic condition specific to pregnant women. Three-dimensional (3D) power Doppler ultrasonography is a technique that utilizes erythrocyte density, scattered intensity, or energy distribution in the bloodstream for imaging purposes. This study aimed to compare the changes in 3D power Doppler ultrasonography parameters in late pregnancy between patients with HDCP and those without HDCP, and to evaluate the predictive value of these parameters for pregnancy outcomes in patients with HDCP. The study included 160 pregnant women diagnosed with HDCP and 100 pregnant women without HDCP, who served as the control group. 3D power Doppler ultrasonography was performed, and the values of the vascularization index (VI), flow index (FI), and vascularization flow index (VFI) were measured. In the HDCP group, the VI, FI, and VFI were all lower than those observed in patients without HDCP. In HDCP patients with positive outcomes, these three parameters were higher than those recorded in patients with negative outcomes. The area under the predicted curve (AUC) for VI, FI, VFI, and the combination of these three parameters were 0.69, 0.63, 0.66, and 0.75, respectively. The parameters of 3D power Doppler ultrasonography can reflect the perfusion status of the placenta and predict the outcome of pregnancy in patients with HDCP. By monitoring these relevant hemodynamic parameters, valuable information can be provided for the clinical diagnosis, objective evaluation, and treatment of HDCP.

Identifiants

pubmed: 37194610
doi: 10.17305/bb.2023.9085
pmc: PMC10494845
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

894-901

Références

J Midwifery Womens Health. 2018 May;63(3):289-300
pubmed: 29764001
Clin Exp Obstet Gynecol. 2010;37(1):26-8
pubmed: 20420276
Ultrasound Obstet Gynecol. 2018 May;51(5):672-676
pubmed: 28397385
Prenat Diagn. 2011 Apr;31(4):367-71
pubmed: 21254145
Placenta. 2011 Feb;32(2):105-15
pubmed: 21115197
J Clin Ultrasound. 2008 Sep;36(7):391-6
pubmed: 18454478
J Coll Physicians Surg Pak. 2020 Aug;30(8):810-814
pubmed: 32893791
Ultrasound Obstet Gynecol. 2008 Sep;32(4):540-50
pubmed: 18686275
Mayo Clin Proc. 2018 Nov;93(11):1664-1677
pubmed: 30392546
J Matern Fetal Neonatal Med. 2016;29(2):218-23
pubmed: 25434644
Clin Obstet Gynecol. 2017 Mar;60(1):206-214
pubmed: 28005588
Pregnancy Hypertens. 2021 Jun;24:13-21
pubmed: 33626437
Am J Epidemiol. 2016 Nov 1;184(9):616-618
pubmed: 27744389
Obstet Gynecol Clin North Am. 2018 Jun;45(2):333-347
pubmed: 29747734
J Clin Ultrasound. 2021 Jan;49(1):12-19
pubmed: 32964472
Arch Gynecol Obstet. 2015 Jul;292(1):75-9
pubmed: 25540056
J Matern Fetal Neonatal Med. 2010 Aug;23(8):894-9
pubmed: 20230318
J Perinat Med. 2017 Aug 28;45(6):693-700
pubmed: 28306539
J Ultrasound Med. 2018 Jul;37(7):1633-1640
pubmed: 29243838
J Perinat Med. 2017 Aug 28;45(6):701-709
pubmed: 28489561
Sports Health. 2021 Sep-Oct;13(5):476-481
pubmed: 33709855
Curr Hypertens Rev. 2017;13(2):80-88
pubmed: 28554307
Hypertension. 2020 Apr;75(4):918-926
pubmed: 32063058
Curr Opin Obstet Gynecol. 2013 Apr;25(2):124-32
pubmed: 23403779
Placenta. 2009 May;30(5):391-7
pubmed: 19327824
Int J Gynaecol Obstet. 2021 Sep;154(3):466-473
pubmed: 33368264
Curr Hypertens Rep. 2019 Nov 27;21(12):96
pubmed: 31776692
Placenta. 2009 Feb;30(2):142-8
pubmed: 19073343
Eur J Obstet Gynecol Reprod Biol. 2020 Nov;254:321-328
pubmed: 33008645
Clin Perinatol. 2019 Jun;46(2):173-185
pubmed: 31010554

Auteurs

Yingying Liu (Y)

Department of Obstetrics, Cangzhou Central Hospital, Cangzhou, China.

Ximei Gao (X)

Medical Department, Cangzhou Central Hospital, Cangzhou, China.

Dandan Shi (D)

Department of Obstetrics, Cangzhou Central Hospital, Cangzhou, China.

Yong Wang (Y)

Department of Obstetrics, Cangzhou Central Hospital, Cangzhou, China.

Xinying Qi (X)

Department of Obstetrics, Cangzhou Central Hospital, Cangzhou, China.

Na Wang (N)

Department of Obstetrics, Cangzhou Central Hospital, Cangzhou, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH